{
  "id": "bc19ea3eb77af2d6",
  "title": "Eli Lilly investors shouldnt sweat rival Novo Nordisk having the first obesity pill on sale",
  "description": "20251223T181500Z",
  "content": "",
  "source": "cnbc.com",
  "source_url": "https://www.cnbc.com/2025/12/23/eli-lilly-investors-shouldnt-sweat-rival-novo-nordisk-having-the-first-obesity-pill-on-sale.html",
  "published_at": "20251223T181500Z",
  "fetched_at": "2025-12-24T00:22:47.431682+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.cnbc.com/2025/12/23/eli-lilly-investors-shouldnt-sweat-rival-novo-nordisk-having-the-first-obesity-pill-on-sale.html",
    "url_mobile": "",
    "title": "Eli Lilly investors shouldnt sweat rival Novo Nordisk having the first obesity pill on sale",
    "seendate": "20251223T181500Z",
    "socialimage": "https://image.cnbcfm.com/api/v1/image/108230191-17637574202025-11-21t203348z_1528530032_rc231ianvoco_rtrmadp_0_usa-stocks.jpeg?v=1763757480",
    "domain": "cnbc.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}